Published in Infect Immun on December 01, 1984
Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A (2000) 2.98
Escherichia coli in extra-intestinal infections. J Hyg (Lond) (1985) 2.51
Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev (2008) 2.45
Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun (1991) 2.22
Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection. Infect Immun (1989) 2.13
Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2003) 2.02
Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Infect Immun (2007) 1.98
Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94
Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One (2010) 1.82
Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A (2003) 1.78
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother (2000) 1.76
Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun (2004) 1.73
Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun (2005) 1.55
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun (2004) 1.48
TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe (2007) 1.47
Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46
Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun (1987) 1.45
Urinary tract infections: new insights into a common problem. Postgrad Med J (2005) 1.44
Host-pathogen interactions mediating pain of urinary tract infection. J Infect Dis (2010) 1.44
The role of Toll-like receptors in renal diseases. Nat Rev Nephrol (2010) 1.42
Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun (2001) 1.40
Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res (2010) 1.40
Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun (2007) 1.39
CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun (2003) 1.38
Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic (2005) 1.35
The Toll-like receptors: analysis by forward genetic methods. Immunogenetics (2005) 1.31
A genetic basis of susceptibility to acute pyelonephritis. PLoS One (2007) 1.28
Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli. PLoS Pathog (2012) 1.22
Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun (2010) 1.19
The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One (2012) 1.19
α-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest (2014) 1.18
Effects of anti-inflammatory agents on mucosal inflammation induced by infection with gram-negative bacteria. Infect Immun (1990) 1.14
Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect Immun (1995) 1.14
Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun (2011) 1.13
The innate immune response during urinary tract infection and pyelonephritis. Pediatr Nephrol (2013) 1.10
Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog (2010) 1.10
Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes. Am J Physiol Renal Physiol (2009) 1.09
Inflection points in sepsis biology: from local defense to systemic organ injury. Am J Physiol Lung Cell Mol Physiol (2012) 1.06
Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect Immun (2006) 1.05
The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock. J Immunol (2009) 1.04
Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. Infect Immun (2005) 1.04
TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol (2008) 1.00
Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun (2012) 0.97
Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence. Infect Immun (2010) 0.96
Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol (2012) 0.96
Quantitative trait loci associated with susceptibility to bladder and kidney infections induced by Escherichia coli in female C3H/HeJ mice. J Infect Dis (2009) 0.94
Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One (2011) 0.91
Sepsis: links between pathogen sensing and organ damage. Curr Pharm Des (2008) 0.90
Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice. Infect Immun (1999) 0.89
Science review: key inflammatory and stress pathways in critical illness - the central role of the Toll-like receptors. Crit Care (2002) 0.88
Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo. J Clin Invest (1992) 0.87
Innate immunity and genetic determinants of urinary tract infection susceptibility. Curr Opin Infect Dis (2015) 0.86
TLR4 facilitates translocation of bacteria across renal collecting duct cells. J Am Soc Nephrol (2008) 0.86
Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin. J Exp Med (2007) 0.85
Resistance of C3H/HeJ mice to the effects of Haemophilus pleuropneumoniae. Infect Immun (1986) 0.85
Toll-like receptors in urothelial cells--targets for cancer immunotherapy. Nat Rev Urol (2013) 0.85
Genetic risk for recurrent urinary tract infections in humans: a systematic review. J Biomed Biotechnol (2010) 0.85
Association of Toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults. PLoS One (2010) 0.85
Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli. Infect Immun (2012) 0.85
Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model. PLoS One (2014) 0.84
Characterization of urinary Escherichia coli O75 strains. J Clin Microbiol (1997) 0.82
Toll-like receptor 2 mediates inhibition of HCO(3)(-) absorption by bacterial lipoprotein in medullary thick ascending limb. Am J Physiol Renal Physiol (2010) 0.81
Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice. MBio (2011) 0.79
Subversion of Host Innate Immunity by Uropathogenic Escherichia coli. Pathogens (2016) 0.79
The toll interleukin-1 receptor (IL-1R) 8/single Ig domain IL-1R-related molecule modulates the renal response to bacterial infection. Infect Immun (2012) 0.79
Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. Microbiol Mol Biol Rev (2016) 0.78
A Murine Model for Escherichia coli Urinary Tract Infection. Methods Mol Biol (2016) 0.77
Comparative tissue transcriptomics reveal prompt inter-organ communication in response to local bacterial kidney infection. BMC Genomics (2011) 0.77
Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli. Sci Rep (2015) 0.76
Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli. Infect Immun (2016) 0.76
The influence of genetic polymorphisms in TLR4 and TIRAP, and their expression levels in peripheral blood, on susceptibility to sepsis. Exp Ther Med (2015) 0.76
Immunity to uropathogens: the emerging roles of inflammasomes. Nat Rev Urol (2017) 0.75
Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci. Physiol Rep (2016) 0.75
Urinary Tract Infection Molecular Mechanisms and Clinical Translation. Pathogens (2016) 0.75
Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract. J Bacteriol (2016) 0.75
LIPOPOLYSACCHARIDE DOMAINS MODULATE UROVIRULENCE. Infect Immun (2016) 0.75
Epigenetic mechanisms regulate innate immunity against uropathogenic and commensal-like Escherichia coli in the surrogate insect model Galleria mellonella. Infect Immun (2017) 0.75
Efficacy of Ceftaroline in a Rat Model of Endocarditis Against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High Inoculum Effect. Antimicrob Agents Chemother (2017) 0.75
Linkage map of Escherichia coli K-12, edition 7. Microbiol Rev (1983) 30.35
Escherichia coli K-12 F-prime factors, old and new. Bacteriol Rev (1972) 18.27
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun (1981) 14.05
Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev (1977) 13.47
Stimulation of natural immunity to Escherichia coli infection: observations on mice. Lancet (1955) 7.17
Kinetic and genetic analyses of D-cycloserine inhibition and resistance in Escherichia coli. J Bacteriol (1965) 5.88
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
Nutrition of the host and natural resistance to infection. V. An improved assay employing genetic markers in the double strain inoculation test. J Exp Med (1956) 4.81
Genetic control of leucocyte responses to endotoxin. Nature (1968) 4.59
Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J Exp Med (1974) 4.48
Resistance of inbred mice to Salmonella typhimurium. J Infect Dis (1972) 4.32
Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol (1980) 3.31
Immunochemistry of R lipopolysaccharides of Escherichia coli. Different core regions in the lipopolysaccharides of O group 8. Eur J Biochem (1969) 2.89
Sensitivity of rough gram-negative bacteria to the bactericidal action of serum. J Bacteriol (1968) 2.68
A proposed mechanism for natural immunity to enterobacterial pathogens. J Immunol (1968) 2.66
Chemical components in the cell wall of Salmonella typhimurium affecting its virulence and immunogenicity in mice. Nature (1969) 2.22
Genetics of hemolysin of Escherichia coli. J Bacteriol (1982) 2.19
Immunochemistry of R lipopolysaccharides of Escherichia coli. Studies on R mutants with an incomplete core, derived from E. coli O8:K27. Eur J Biochem (1970) 2.18
Mitogenic stimulation of murine spleen cells: relation to susceptibility to Salmonella infection. Infect Immun (1977) 1.68
The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol (1977) 1.64
Role of O-antigen (lipopolysaccharide) factors in the virulence of Salmonella. J Infect Dis (1973) 1.57
Surface charge and hydrophobicity of Salmonella, E. coli, Gonococci in relation to their tendency to associate with animal cells. Scand J Infect Dis Suppl (1980) 1.35
Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage. Infect Immun (1982) 1.28
Genetic control of the susceptibility of C3HeB/FeJ mice to Salmonella typhimurium is regulated by a locus distinct from known salmonella response genes. J Immunol (1983) 1.23
Genetic and immunochemical studies on Escherichia coli O14:K7:H-. Eur J Biochem (1974) 1.21
In vitro stimulation of C3H/HeJ spleen cells and macrophages by a lipid A precursor molecule derived from Salmonella typhimurium. J Immunol (1984) 1.08
Genetic factors in host resistance to urinary tract infection. Infection (1984) 0.99
Experimental Escherichia coli ascending pyelonephritis in rats: changes in bacterial properties and the immune response to surface antigens. Infect Immun (1982) 0.89
Virulence of Salmonella strains with a reduced amount of O-antigen. J Gen Microbiol (1969) 0.82
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol (1987) 4.53
A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol (2001) 4.39
Genetics of digalactoside-binding adhesin from a uropathogenic Escherichia coli strain. Infect Immun (1983) 4.03
A bactericidal effect for human lactoferrin. Science (1977) 3.73
A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol (1973) 3.65
Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55
Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature (1982) 3.50
Molecular cloning and physical characterization of a chromosomal hemolysin from Escherichia coli. Infect Immun (1983) 3.30
Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med (1989) 3.28
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med (1982) 3.16
Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections. Prog Allergy (1983) 3.12
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med (1979) 2.91
Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol (1995) 2.87
Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity. Science (1976) 2.78
Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis (1999) 2.75
Effective immunity to dental caries: protection of gnotobiotic rats by local immunization with Streptococcus mutans. J Immunol (1975) 2.71
Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest (1978) 2.64
Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med (1993) 2.62
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol (1987) 2.37
IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A (1987) 2.37
Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immun (1981) 2.33
Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol (1996) 2.30
Retroid virus genome replication. Adv Virus Res (1987) 2.23
Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp (1981) 2.15
The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition. Infect Immun (1990) 2.14
Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection. Infect Immun (1989) 2.13
The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J Infect Dis (1980) 2.11
Aspects on structure and function of pili on uropathogenic Escherichia coli. Prog Allergy (1983) 2.11
A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci U S A (1997) 2.07
Dynamic microscopy of nanoscale cluster growth at the solid-liquid interface. Nat Mater (2003) 2.07
Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol (2000) 2.06
An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages. J Immunol Methods (1982) 2.06
Immunobiology of dental caries: microbial aspects and local immunity. Annu Rev Microbiol (1981) 2.04
Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis. N Engl J Med (1981) 2.04
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol (2005) 2.04
Cariogenicity of Streptococcus mutans V403 glucosyltransferase and fructosyltransferase mutants constructed by allelic exchange. Infect Immun (1991) 2.00
Virulence of Streptococcus mutans: a sensitive method for evaluating cariogenicity in young gnotobiotic rats. Infect Immun (1975) 2.00
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol (2000) 2.00
A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect Immun (1988) 1.95
Model for vesicular stomatitis virus. J Virol (1972) 1.92
Accessory cells in murine Peyer's patch. I. Identification and enrichment of a functional dendritic cell. J Exp Med (1983) 1.92
Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun (1991) 1.86
Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva. Infect Immun (1976) 1.85
Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol (1988) 1.80
Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci U S A (1999) 1.79
Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect Immun (1993) 1.78
Characterisation of cauliflower mosaic virus DNA sequences which encode major polyadenylated transcripts. Nucleic Acids Res (1981) 1.77
Replication of cauliflower mosaic virus and transcription of its genome in turnip leaf protoplasts. Virology (1978) 1.76
Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol (1996) 1.76
Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods (1990) 1.74
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology (2005) 1.73
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens. J Exp Med (1979) 1.73
Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol (1994) 1.73
Virulence of Streptococcus mutans: biochemical and pathogenic characteristics of mutant isolates. Proc Soc Exp Biol Med (1975) 1.73
Construction and comparison of recombinant plasmids encoding type 1 fimbriae of members of the family Enterobacteriaceae. Infect Immun (1985) 1.70
Molecular mechanisms of immunoglobulin A defense. Annu Rev Microbiol (1989) 1.70
Mucosal immunity, HIV transmission, and AIDS. Lab Invest (1993) 1.69
Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med (1999) 1.69
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis (1996) 1.68
Binding specificity of piliated strains of Escherichia coli and Salmonella typhimurium to epithelial cells, saccharomyces cerevisiae cells, and erythrocytes. Infect Immun (1981) 1.68
Analysis of Th1 and Th2 cells in murine gut-associated tissues. Frequencies of CD4+ and CD8+ T cells that secrete IFN-gamma and IL-5. J Immunol (1990) 1.67
Combined use of leg scanning and impedance plethysmography in suspected venous thrombosis. An alternative to venography. N Engl J Med (1977) 1.66
Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun (1989) 1.65
Molecular biology of viral and nonviral retroelements. Trends Genet (1989) 1.65
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med (1982) 1.64
Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology (1999) 1.63
Rat immunoglobulins in serum and secretions: purification of rat IgM, IgA and IgG and their quantitation in serum, colostrum, milk and saliva. Immunochemistry (1975) 1.61
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J Infect Dis (2000) 1.61
Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med (1997) 1.61
Regulation of host immune responses by modification of Salmonella virulence genes. Nat Med (1998) 1.59
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol (2001) 1.59
Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5. J Immunol (1991) 1.58